Substances · Lysergamides
ETH-LAD
- Preferred name
- ETH-LAD
- IUPAC name
- (6aR,9R)-N,N,7-triethyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
- Parent CAS number (reference)
- 65527-61-9
- Molecular formula
- C21H27N3O
- Molecular weight
- 337.5 g/mol
- InChIKey
- MYNOUXJLOHVSMQ-DNVCBOLYSA-N
- PubChem
- CID 44457783
- Source
- PubChem
- Verified synonyms & catalog abbreviations
-
6-Ethyl-6-nor-LSD ETHLAD ETH LAD
Matching Listings in This Store's Catalog
Verified Neurochemical & Toxicological Intelligence
ETH-LAD
Receptor Telemetry & Mechanism of Action
Direct N6-ethyl-nor-LSD agonist showing slightly higher in vitro 5-HT2A affinity than LSD-25 itself.
Biotransformation & Active Metabolites
Directly active without conversion to LSD-25.
Temporal Pharmacokinetics
Potent N6-Ethyl Lysergamide (5-HT2A Partial Agonist) — Supplied as dissolved liquid solution; ~20–30% steeper per microgram than 1P-LSD/1cP-LSD with pronounced visual density and early somatic thermoregulation/nausea sensitivity above 120 ug.
- Onset 30–75 min
- Peak Window 2–4 h
- Total Window 8–12 h
- Residual / Half-Life 4–8 h residual
Supplied as dissolved liquid solution; ~20–30% steeper per microgram than 1P-LSD/1cP-LSD with pronounced visual density and early somatic thermoregulation/nausea sensitivity above 120 ug.
Quantitative Response Spectrum (Published Literature)
Third-person observational & toxicological brackets reported in scientific and harm-reduction literature — reference telemetry only, never consumption advice.
15–20 ug
Subtle threshold receptor activity (Potent N6-Ethyl Lysergamide (5-HT2A Partial Agonist)).
Minimal baseline autonomic shift.
20–60 ug
Mild, clear-headed expression of primary class profile.
Light somatic modulation.
60–120 ug
Full characteristic neurochemical and perceptual profile documented in literature.
Moderate somatic relaxation, ataxia, or autonomic tone depending on class.
120–200 ug
Pronounced intensity, cognitive/motor impairment, or deep immersion.
Marked somatic load and heightened adverse-event sensitivity.
200+ ug
Amnesia, blackout, acute dysphoria, confusion, or anesthetic dissociation.
High toxicity zone: severe motor loss, cardiovascular strain, or respiratory hazard.
Interaction Matrix & Critical Contraindications
Critical Hazard — Never Combine
Strongly documented to provoke acute tonic-clonic seizures, fugue states, and severe psychotic episodes with lysergamides.
Lowers seizure threshold alongside 5-HT2A excitation.
Elevated Hazard — Avoid
Exponentially amplifies thought loops, tachycardia, anxiety, and acute paranoia.
Caution / Receptor Attenuation
Chronic SSRIs and acute benzodiazepines markedly attenuate 5-HT2A perceptual effects.
Structural Isomer & Sibling Comparison
Supplied as dissolved liquid solution; ~20–30% steeper per microgram than 1P-LSD/1cP-LSD with pronounced visual density and early somatic thermoregulation/nausea sensitivity above 120 ug.
Physicochemical Stability & Storage
Form: Clear, colorless calibrated liquid solution for microgram (µg) volumetric measurement. · Supplied pre-dissolved in analytical carrier; sensitive to chlorine/tap water.
Highly sensitive to UV light, heat, and chlorine; store airtight in amber glass under cold/refrigerated conditions.
Cross-Tolerance & Dependence Profile
Immediate rapid 5-HT2A receptor downregulation within hours, cross-tolerant with all tryptamines and phenethylamines; baseline sensitivity typically resets over 10–14 days. Non-addictive physiologically.
Chemical Architecture & Structural Profile
ETH-LAD ((6aR,9R)-N,N,7-triethyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide) is a reference compound belonging to the Lysergamides class, characterized by the molecular formula C21H27N3O and a molar mass of 337.5 g/mol. The parent molecule is indexed under CAS registry number 65527-61-9 and in the NCBI PubChem database as CID 44457783 (Standard InChIKey: MYNOUXJLOHVSMQ-DNVCBOLYSA-N).
Citations
- PubChem — PubChem (2026-11-12)
Reference Toxicology & Safety Profile
In documented chemical and harm-reduction literature (PubChem / PsychonautWiki, CC BY 4.0), ETH-LAD is indexed within the Lysergamides structural group. Toxicological notes (PsychonautWiki): toxic dose is unknown. Dependence liability (PsychonautWiki): not habit-forming. Documented cross-tolerance class: psychedelic. Standard laboratory handling precautions—including nitrile gloves, eye protection, and local exhaust ventilation—apply whenever handling the reference material.
Citations
- PubChem — PubChem (2026-11-12)
Analytical Use & Laboratory Notice
This reference sheet provides chemical, analytical, and toxicological provenance only. The material is strictly not for human consumption, diagnostic, or veterinary use. Research-use labelling does not establish legal status in any jurisdiction.
Citations
- Federal Register of Legislation — Therapeutic Goods (Poisons Standard) — Australian Government (2026-11-12)